Grant Opportunities in Medicine
Bridging Research and Resources for Tomorrow's Discoveries
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Supporting research to improve care and well-being for people exposed to the September 11, 2001 terrorist attacks and to identify emerging conditions within affected populations.
Published At
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Supports exploratory/developmental research to address diagnostic or treatment uncertainty for 9/11-exposed populations, assessing feasibility of new interventions and approaches.
Published At
2026 Hemophilia Fellowship – United States
Pfizer offers a $100,000 USD fellowship for US-based academic institutions to support hemophilia care through shared decision making, patient education, and multidisciplinary care.
Published At
Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
Pfizer Inc. invites proposals for educational programs on the mechanism of action of JAK3 and TEC family kinases in alopecia areata for dermatologists and healthcare professionals.
Published At
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
The National Cancer Institute (NCI) solicits applications from academic organizations to establish Lead Academic Organizations within the ETCTN clinical trials network.
Published At
Developing Educational Initiatives for Implementation and Therapy Management of B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
Pfizer offers grants up to $125,000 to US healthcare organizations to improve professional competency in managing BCMA BsAbs for Relapsed/Refractory Multiple Myeloma.
Published At
Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
Pfizer Inc. offers a research grant for medical societies and professional organizations to develop a shared decision-making tool for patients with ATTR-CM.
Published At
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
NIAID offers R24 grants for investigator-initiated resource-related research projects to support the development of new resources for the scientific community.
Published At
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
The National Institutes of Health supports research into AI/ML-driven tools and glucose control technologies to improve glycemic control and quality of life for people with T1D.
Published At
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
NIAID invites P01 applications for research on infectious microbes, HIV, and immune dysfunction. Supports synergistic research projects and administrative cores.
Published At